Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study.

Carolina Sciortino, Valentina Viglialoro, Massimo Nucci, Mariam Grazia Polito,Enrico Cortesi,Alain Gelibter,Paola Gazzaniga,Chiara Nicolazzo,Marco Siringo,Salvatore Caponnetto

Oncotarget(2022)

Cited 3|Views5
No score
Abstract
The results of this study do not reveal a clear correlation between mutation and response to immunotherapy. The mechanism regulating immune system activity in the tumor microenvironment remains unclear.
More
Translated text
Key words
KRAS G12C mutation,NSCLC,immunotherapy,liquid biopsy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined